GEHC GE HEALTHCARE TECHNOLOGY
2026Q1 · CUSIP 36266G107 · Sector: Healthcare & Biotech
Danger · Dual-confirm: breadth + price
Holders
1,254
Δ holders QoQ
-69
Breadth percentile
Top 98%
Whale holders
308
Δ whales
+5
Inst. holding value
$26.9B
New positions
126
Closed positions
195
Price momentum (1Q)
-24.6%
Put / Call
19/24
Breadth history (34 quarters)
Past Lit Events & Aftermath 9 lit events
| Period | Percentile | Next-1Q return | Next-2Q return |
|---|---|---|---|
| 2025Q4 | Top 8% | -24.6% | — |
| 2025Q1 | Top 5% | +1.2% | -3.3% |
| 2024Q4 | Top 8% | -21.1% | -20.1% |
| 2024Q3 | Top 3% | +10.2% | -16.0% |
| 2024Q1 | Top 2% | +4.6% | -0.1% |
| 2023Q4 | Top 6% | -4.8% | -0.4% |
| 2023Q2 | Top 2% | +2.2% | +21.3% |
| 2023Q1 | Top 0% | -14.8% | -10.8% |
| 2022Q4 | Top 9% | +12.4% | -3.5% |
Options Sentiment
Put holders
19
QoQ: -1
Call holders
24
QoQ: +2
See methodology →
Fundamentals
PE (TTM)
15.1
EPS (TTM)
$4.17
EPS YoY
-12.4%
Revenue (TTM)
$21.0B
Revenue YoY
+6.0%
Net margin
9.1%
ROE
17.9%
Debt ratio
70.7%
FCF (TTM)
—
Dividend (TTM)
No dividend
Quarterly Revenue & EPS (4Y)
Quarterly figures; EPS split-adjusted, early quarters hidden when not calibrable
P/E (TTM) over time
P/E = close 47 days after quarter-end (filing date) ÷ TTM EPS then; loss quarters hidden
As of 2026-03-31 · SEC filings (XBRL)
Get the next update
2026Q2 holdings publish around Aug 15 — subscribe to receive the lists first.